 | • レポートコード：MRC2-11QY06748 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はジェネリック注射剤のグローバル市場について調査・分析したレポートです。種類別（大分子注射剤（バイオシミラー）、小分子注射剤）市場規模、用途別（腫瘍学、感染症、心臓病学、糖尿病、免疫学）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ジェネリック注射剤の競争状況、市場シェア ・世界のジェネリック注射剤市場：種類別市場規模 2015年-2020年（大分子注射剤（バイオシミラー）、小分子注射剤） ・世界のジェネリック注射剤市場：種類別市場規模予測 2021年-2026年（大分子注射剤（バイオシミラー）、小分子注射剤） ・世界のジェネリック注射剤市場：用途別市場規模 2015年-2020年（腫瘍学、感染症、心臓病学、糖尿病、免疫学） ・世界のジェネリック注射剤市場：用途別市場規模予測 2021年-2026年（腫瘍学、感染症、心臓病学、糖尿病、免疫学） ・北米のジェネリック注射剤市場分析：米国、カナダ ・ヨーロッパのジェネリック注射剤市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのジェネリック注射剤市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のジェネリック注射剤市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのジェネリック注射剤市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Pfizer、Sandoz International、Baxter、Fresenius、Mylan、Teva Pharmaceutical、Hikma Pharmaceuticals、Lupin Pharmaceuticals、Sanofi、Biocon ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Generic injectables are bio-equivalents of their branded counterparts which are not protected by drug patents. They are as safe and effective as the innovator drugs since they have similar active ingredient, dosage, strength, quality, form, etc.
Market Analysis and Insights: Global Generic Injectables Market
The global Generic Injectables market size is projected to reach US$ 26870 million by 2026, from US$ 25420 million in 2020, at a CAGR of 5.3%% during 2021-2026.
Global Generic Injectables Scope and Market Size
Generic Injectables market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Generic Injectables market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Generic Injectables market is segmented into
Large Molecule Injectables (Biosimilars)
Small Molecule Injectables
Segment by Application, the Generic Injectables market is segmented into
Oncology
Infectious Diseases
Cardiology
Diabetes
Immunology
Regional and Country-level Analysis
The Generic Injectables market is analysed and market size information is provided by regions (countries).
The key regions covered in the Generic Injectables market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Generic Injectables Market Share Analysis
Generic Injectables market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Generic Injectables business, the date to enter into the Generic Injectables market, Generic Injectables product introduction, recent developments, etc.
The major vendors covered:
Pfizer
Sandoz International
Baxter
Fresenius
Mylan
Teva Pharmaceutical
Hikma Pharmaceuticals
Lupin Pharmaceuticals
Sanofi
Biocon
1 Study Coverage
1.1 Generic Injectables Product Introduction
1.2 Market Segments
1.3 Key Generic Injectables Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Generic Injectables Market Size Growth Rate by Type
1.4.2 Large Molecule Injectables (Biosimilars)
1.4.3 Small Molecule Injectables
1.5 Market by Application
1.5.1 Global Generic Injectables Market Size Growth Rate by Application
1.5.2 Oncology
1.5.3 Infectious Diseases
1.5.4 Cardiology
1.5.5 Diabetes
1.5.6 Immunology
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Generic Injectables Market Size, Estimates and Forecasts
2.1.1 Global Generic Injectables Revenue 2015-2026
2.1.2 Global Generic Injectables Sales 2015-2026
2.2 Global Generic Injectables, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Generic Injectables Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Generic Injectables Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Generic Injectables Competitor Landscape by Players
3.1 Generic Injectables Sales by Manufacturers
3.1.1 Generic Injectables Sales by Manufacturers (2015-2020)
3.1.2 Generic Injectables Sales Market Share by Manufacturers (2015-2020)
3.2 Generic Injectables Revenue by Manufacturers
3.2.1 Generic Injectables Revenue by Manufacturers (2015-2020)
3.2.2 Generic Injectables Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Generic Injectables Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Generic Injectables Revenue in 2019
3.2.5 Global Generic Injectables Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Generic Injectables Price by Manufacturers
3.4 Generic Injectables Manufacturing Base Distribution, Product Types
3.4.1 Generic Injectables Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Generic Injectables Product Type
3.4.3 Date of International Manufacturers Enter into Generic Injectables Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Generic Injectables Market Size by Type (2015-2020)
4.1.1 Global Generic Injectables Sales by Type (2015-2020)
4.1.2 Global Generic Injectables Revenue by Type (2015-2020)
4.1.3 Generic Injectables Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Generic Injectables Market Size Forecast by Type (2021-2026)
4.2.1 Global Generic Injectables Sales Forecast by Type (2021-2026)
4.2.2 Global Generic Injectables Revenue Forecast by Type (2021-2026)
4.2.3 Generic Injectables Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Generic Injectables Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Generic Injectables Market Size by Application (2015-2020)
5.1.1 Global Generic Injectables Sales by Application (2015-2020)
5.1.2 Global Generic Injectables Revenue by Application (2015-2020)
5.1.3 Generic Injectables Price by Application (2015-2020)
5.2 Generic Injectables Market Size Forecast by Application (2021-2026)
5.2.1 Global Generic Injectables Sales Forecast by Application (2021-2026)
5.2.2 Global Generic Injectables Revenue Forecast by Application (2021-2026)
5.2.3 Global Generic Injectables Price Forecast by Application (2021-2026)
6 North America
6.1 North America Generic Injectables by Country
6.1.1 North America Generic Injectables Sales by Country
6.1.2 North America Generic Injectables Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Generic Injectables Market Facts & Figures by Type
6.3 North America Generic Injectables Market Facts & Figures by Application
7 Europe
7.1 Europe Generic Injectables by Country
7.1.1 Europe Generic Injectables Sales by Country
7.1.2 Europe Generic Injectables Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Generic Injectables Market Facts & Figures by Type
7.3 Europe Generic Injectables Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Generic Injectables by Region
8.1.1 Asia Pacific Generic Injectables Sales by Region
8.1.2 Asia Pacific Generic Injectables Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Generic Injectables Market Facts & Figures by Type
8.3 Asia Pacific Generic Injectables Market Facts & Figures by Application
9 Latin America
9.1 Latin America Generic Injectables by Country
9.1.1 Latin America Generic Injectables Sales by Country
9.1.2 Latin America Generic Injectables Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Generic Injectables Market Facts & Figures by Type
9.3 Central & South America Generic Injectables Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Generic Injectables by Country
10.1.1 Middle East and Africa Generic Injectables Sales by Country
10.1.2 Middle East and Africa Generic Injectables Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Generic Injectables Market Facts & Figures by Type
10.3 Middle East and Africa Generic Injectables Market Facts & Figures by Application
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description and Business Overview
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Generic Injectables Products Offered
11.1.5 Pfizer Related Developments
11.2 Sandoz International
11.2.1 Sandoz International Corporation Information
11.2.2 Sandoz International Description and Business Overview
11.2.3 Sandoz International Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Sandoz International Generic Injectables Products Offered
11.2.5 Sandoz International Related Developments
11.3 Baxter
11.3.1 Baxter Corporation Information
11.3.2 Baxter Description and Business Overview
11.3.3 Baxter Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Baxter Generic Injectables Products Offered
11.3.5 Baxter Related Developments
11.4 Fresenius
11.4.1 Fresenius Corporation Information
11.4.2 Fresenius Description and Business Overview
11.4.3 Fresenius Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Fresenius Generic Injectables Products Offered
11.4.5 Fresenius Related Developments
11.5 Mylan
11.5.1 Mylan Corporation Information
11.5.2 Mylan Description and Business Overview
11.5.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Mylan Generic Injectables Products Offered
11.5.5 Mylan Related Developments
11.6 Teva Pharmaceutical
11.6.1 Teva Pharmaceutical Corporation Information
11.6.2 Teva Pharmaceutical Description and Business Overview
11.6.3 Teva Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Teva Pharmaceutical Generic Injectables Products Offered
11.6.5 Teva Pharmaceutical Related Developments
11.7 Hikma Pharmaceuticals
11.7.1 Hikma Pharmaceuticals Corporation Information
11.7.2 Hikma Pharmaceuticals Description and Business Overview
11.7.3 Hikma Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Hikma Pharmaceuticals Generic Injectables Products Offered
11.7.5 Hikma Pharmaceuticals Related Developments
11.8 Lupin Pharmaceuticals
11.8.1 Lupin Pharmaceuticals Corporation Information
11.8.2 Lupin Pharmaceuticals Description and Business Overview
11.8.3 Lupin Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Lupin Pharmaceuticals Generic Injectables Products Offered
11.8.5 Lupin Pharmaceuticals Related Developments
11.9 Sanofi
11.9.1 Sanofi Corporation Information
11.9.2 Sanofi Description and Business Overview
11.9.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Sanofi Generic Injectables Products Offered
11.9.5 Sanofi Related Developments
11.10 Biocon
11.10.1 Biocon Corporation Information
11.10.2 Biocon Description and Business Overview
11.10.3 Biocon Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Biocon Generic Injectables Products Offered
11.10.5 Biocon Related Developments
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description and Business Overview
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Generic Injectables Products Offered
11.1.5 Pfizer Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Generic Injectables Market Estimates and Projections by Region
12.1.1 Global Generic Injectables Sales Forecast by Regions 2021-2026
12.1.2 Global Generic Injectables Revenue Forecast by Regions 2021-2026
12.2 North America Generic Injectables Market Size Forecast (2021-2026)
12.2.1 North America: Generic Injectables Sales Forecast (2021-2026)
12.2.2 North America: Generic Injectables Revenue Forecast (2021-2026)
12.2.3 North America: Generic Injectables Market Size Forecast by Country (2021-2026)
12.3 Europe Generic Injectables Market Size Forecast (2021-2026)
12.3.1 Europe: Generic Injectables Sales Forecast (2021-2026)
12.3.2 Europe: Generic Injectables Revenue Forecast (2021-2026)
12.3.3 Europe: Generic Injectables Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Generic Injectables Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Generic Injectables Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Generic Injectables Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Generic Injectables Market Size Forecast by Region (2021-2026)
12.5 Latin America Generic Injectables Market Size Forecast (2021-2026)
12.5.1 Latin America: Generic Injectables Sales Forecast (2021-2026)
12.5.2 Latin America: Generic Injectables Revenue Forecast (2021-2026)
12.5.3 Latin America: Generic Injectables Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Generic Injectables Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Generic Injectables Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Generic Injectables Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Generic Injectables Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Generic Injectables Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Generic Injectables Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Generic Injectables Market Segments
Table 2. Ranking of Global Top Generic Injectables Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Generic Injectables Market Size Growth Rate by Type 2020-2026 (Kg) & (US$ Million)
Table 4. Major Manufacturers of Large Molecule Injectables (Biosimilars)
Table 5. Major Manufacturers of Small Molecule Injectables
Table 6. Global Generic Injectables Market Size Growth Rate by Application 2020-2026 (Kg)
Table 7. Global Generic Injectables Market Size by Region (Kg) & (US$ Million): 2020 VS 2026
Table 8. Global Generic Injectables Sales by Regions 2015-2020 (Kg)
Table 9. Global Generic Injectables Sales Market Share by Regions (2015-2020)
Table 10. Global Generic Injectables Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Generic Injectables Sales by Manufacturers (2015-2020) (Kg)
Table 12. Global Generic Injectables Sales Share by Manufacturers (2015-2020)
Table 13. Global Generic Injectables Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Generic Injectables by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Generic Injectables as of 2019)
Table 15. Generic Injectables Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Generic Injectables Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Generic Injectables Price (2015-2020) (USD/Kg)
Table 18. Generic Injectables Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Generic Injectables Product Type
Table 20. Date of International Manufacturers Enter into Generic Injectables Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Generic Injectables Sales by Type (2015-2020) (Kg)
Table 23. Global Generic Injectables Sales Share by Type (2015-2020)
Table 24. Global Generic Injectables Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Generic Injectables Revenue Share by Type (2015-2020)
Table 26. Generic Injectables Average Selling Price (ASP) by Type 2015-2020 (USD/Kg)
Table 27. Global Generic Injectables Sales by Application (2015-2020) (Kg)
Table 28. Global Generic Injectables Sales Share by Application (2015-2020)
Table 29. North America Generic Injectables Sales by Country (2015-2020) (Kg)
Table 30. North America Generic Injectables Sales Market Share by Country (2015-2020)
Table 31. North America Generic Injectables Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Generic Injectables Revenue Market Share by Country (2015-2020)
Table 33. North America Generic Injectables Sales by Type (2015-2020) (Kg)
Table 34. North America Generic Injectables Sales Market Share by Type (2015-2020)
Table 35. North America Generic Injectables Sales by Application (2015-2020) (Kg)
Table 36. North America Generic Injectables Sales Market Share by Application (2015-2020)
Table 37. Europe Generic Injectables Sales by Country (2015-2020) (Kg)
Table 38. Europe Generic Injectables Sales Market Share by Country (2015-2020)
Table 39. Europe Generic Injectables Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Generic Injectables Revenue Market Share by Country (2015-2020)
Table 41. Europe Generic Injectables Sales by Type (2015-2020) (Kg)
Table 42. Europe Generic Injectables Sales Market Share by Type (2015-2020)
Table 43. Europe Generic Injectables Sales by Application (2015-2020) (Kg)
Table 44. Europe Generic Injectables Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Generic Injectables Sales by Region (2015-2020) (Kg)
Table 46. Asia Pacific Generic Injectables Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Generic Injectables Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Generic Injectables Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Generic Injectables Sales by Type (2015-2020) (Kg)
Table 50. Asia Pacific Generic Injectables Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Generic Injectables Sales by Application (2015-2020) (Kg)
Table 52. Asia Pacific Generic Injectables Sales Market Share by Application (2015-2020)
Table 53. Latin America Generic Injectables Sales by Country (2015-2020) (Kg)
Table 54. Latin America Generic Injectables Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Generic Injectables Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Generic Injectables Revenue Market Share by Country (2015-2020)
Table 57. Latin America Generic Injectables Sales by Type (2015-2020) (Kg)
Table 58. Latin America Generic Injectables Sales Market Share by Type (2015-2020)
Table 59. Latin America Generic Injectables Sales by Application (2015-2020) (Kg)
Table 60. Latin America Generic Injectables Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Generic Injectables Sales by Country (2015-2020) (Kg)
Table 62. Middle East and Africa Generic Injectables Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Generic Injectables Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Generic Injectables Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Generic Injectables Sales by Type (2015-2020) (Kg)
Table 66. Middle East and Africa Generic Injectables Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Generic Injectables Sales by Application (2015-2020) (Kg)
Table 68. Middle East and Africa Generic Injectables Sales Market Share by Application (2015-2020)
Table 69. Pfizer Corporation Information
Table 70. Pfizer Description and Major Businesses
Table 71. Pfizer Generic Injectables Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 72. Pfizer Product
Table 73. Pfizer Recent Development
Table 74. Sandoz International Corporation Information
Table 75. Sandoz International Description and Major Businesses
Table 76. Sandoz International Generic Injectables Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 77. Sandoz International Product
Table 78. Sandoz International Recent Development
Table 79. Baxter Corporation Information
Table 80. Baxter Description and Major Businesses
Table 81. Baxter Generic Injectables Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 82. Baxter Product
Table 83. Baxter Recent Development
Table 84. Fresenius Corporation Information
Table 85. Fresenius Description and Major Businesses
Table 86. Fresenius Generic Injectables Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 87. Fresenius Product
Table 88. Fresenius Recent Development
Table 89. Mylan Corporation Information
Table 90. Mylan Description and Major Businesses
Table 91. Mylan Generic Injectables Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 92. Mylan Product
Table 93. Mylan Recent Development
Table 94. Teva Pharmaceutical Corporation Information
Table 95. Teva Pharmaceutical Description and Major Businesses
Table 96. Teva Pharmaceutical Generic Injectables Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 97. Teva Pharmaceutical Product
Table 98. Teva Pharmaceutical Recent Development
Table 99. Hikma Pharmaceuticals Corporation Information
Table 100. Hikma Pharmaceuticals Description and Major Businesses
Table 101. Hikma Pharmaceuticals Generic Injectables Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 102. Hikma Pharmaceuticals Product
Table 103. Hikma Pharmaceuticals Recent Development
Table 104. Lupin Pharmaceuticals Corporation Information
Table 105. Lupin Pharmaceuticals Description and Major Businesses
Table 106. Lupin Pharmaceuticals Generic Injectables Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 107. Lupin Pharmaceuticals Product
Table 108. Lupin Pharmaceuticals Recent Development
Table 109. Sanofi Corporation Information
Table 110. Sanofi Description and Major Businesses
Table 111. Sanofi Generic Injectables Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 112. Sanofi Product
Table 113. Sanofi Recent Development
Table 114. Biocon Corporation Information
Table 115. Biocon Description and Major Businesses
Table 116. Biocon Generic Injectables Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 117. Biocon Product
Table 118. Biocon Recent Development
Table 119. Global Generic Injectables Sales Forecast by Regions (2021-2026) (Kg)
Table 120. Global Generic Injectables Sales Market Share Forecast by Regions (2021-2026)
Table 121. Global Generic Injectables Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 122. Global Generic Injectables Revenue Market Share Forecast by Regions (2021-2026)
Table 123. North America: Generic Injectables Sales Forecast by Country (2021-2026) (Kg)
Table 124. North America: Generic Injectables Revenue Forecast by Country (2021-2026) (US$ Million)
Table 125. Europe: Generic Injectables Sales Forecast by Country (2021-2026) (Kg)
Table 126. Europe: Generic Injectables Revenue Forecast by Country (2021-2026) (US$ Million)
Table 127. Asia Pacific: Generic Injectables Sales Forecast by Region (2021-2026) (Kg)
Table 128. Asia Pacific: Generic Injectables Revenue Forecast by Region (2021-2026) (US$ Million)
Table 129. Latin America: Generic Injectables Sales Forecast by Country (2021-2026) (Kg)
Table 130. Latin America: Generic Injectables Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Middle East and Africa: Generic Injectables Sales Forecast by Country (2021-2026) (Kg)
Table 132. Middle East and Africa: Generic Injectables Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 134. Key Challenges
Table 135. Market Risks
Table 136. Main Points Interviewed from Key Generic Injectables Players
Table 137. Generic Injectables Customers List
Table 138. Generic Injectables Distributors List
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Generic Injectables Product Picture
Figure 2. Global Generic Injectables Sales Market Share by Type in 2020 & 2026
Figure 3. Large Molecule Injectables (Biosimilars) Product Picture
Figure 4. Small Molecule Injectables Product Picture
Figure 5. Global Generic Injectables Sales Market Share by Application in 2020 & 2026
Figure 6. Oncology
Figure 7. Infectious Diseases
Figure 8. Cardiology
Figure 9. Diabetes
Figure 10. Immunology
Figure 11. Generic Injectables Report Years Considered
Figure 12. Global Generic Injectables Market Size 2015-2026 (US$ Million)
Figure 13. Global Generic Injectables Sales 2015-2026 (Kg)
Figure 14. Global Generic Injectables Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Generic Injectables Sales Market Share by Region (2015-2020)
Figure 16. Global Generic Injectables Sales Market Share by Region in 2019
Figure 17. Global Generic Injectables Revenue Market Share by Region (2015-2020)
Figure 18. Global Generic Injectables Revenue Market Share by Region in 2019
Figure 19. Global Generic Injectables Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Generic Injectables Revenue in 2019
Figure 21. Generic Injectables Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Generic Injectables Sales Market Share by Type (2015-2020)
Figure 23. Global Generic Injectables Sales Market Share by Type in 2019
Figure 24. Global Generic Injectables Revenue Market Share by Type (2015-2020)
Figure 25. Global Generic Injectables Revenue Market Share by Type in 2019
Figure 26. Global Generic Injectables Market Share by Price Range (2015-2020)
Figure 27. Global Generic Injectables Sales Market Share by Application (2015-2020)
Figure 28. Global Generic Injectables Sales Market Share by Application in 2019
Figure 29. Global Generic Injectables Revenue Market Share by Application (2015-2020)
Figure 30. Global Generic Injectables Revenue Market Share by Application in 2019
Figure 31. North America Generic Injectables Sales Growth Rate 2015-2020 (Kg)
Figure 32. North America Generic Injectables Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Generic Injectables Sales Market Share by Country in 2019
Figure 34. North America Generic Injectables Revenue Market Share by Country in 2019
Figure 35. U.S. Generic Injectables Sales Growth Rate (2015-2020) (Kg)
Figure 36. U.S. Generic Injectables Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Generic Injectables Sales Growth Rate (2015-2020) (Kg)
Figure 38. Canada Generic Injectables Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Generic Injectables Market Share by Type in 2019
Figure 40. North America Generic Injectables Market Share by Application in 2019
Figure 41. Europe Generic Injectables Sales Growth Rate 2015-2020 (Kg)
Figure 42. Europe Generic Injectables Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Generic Injectables Sales Market Share by Country in 2019
Figure 44. Europe Generic Injectables Revenue Market Share by Country in 2019
Figure 45. Germany Generic Injectables Sales Growth Rate (2015-2020) (Kg)
Figure 46. Germany Generic Injectables Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Generic Injectables Sales Growth Rate (2015-2020) (Kg)
Figure 48. France Generic Injectables Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Generic Injectables Sales Growth Rate (2015-2020) (Kg)
Figure 50. U.K. Generic Injectables Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Generic Injectables Sales Growth Rate (2015-2020) (Kg)
Figure 52. Italy Generic Injectables Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Generic Injectables Sales Growth Rate (2015-2020) (Kg)
Figure 54. Russia Generic Injectables Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Generic Injectables Market Share by Type in 2019
Figure 56. Europe Generic Injectables Market Share by Application in 2019
Figure 57. Asia Pacific Generic Injectables Sales Growth Rate 2015-2020 (Kg)
Figure 58. Asia Pacific Generic Injectables Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Generic Injectables Sales Market Share by Region in 2019
Figure 60. Asia Pacific Generic Injectables Revenue Market Share by Region in 2019
Figure 61. China Generic Injectables Sales Growth Rate (2015-2020) (Kg)
Figure 62. China Generic Injectables Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Generic Injectables Sales Growth Rate (2015-2020) (Kg)
Figure 64. Japan Generic Injectables Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Generic Injectables Sales Growth Rate (2015-2020) (Kg)
Figure 66. South Korea Generic Injectables Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Generic Injectables Sales Growth Rate (2015-2020) (Kg)
Figure 68. India Generic Injectables Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Generic Injectables Sales Growth Rate (2015-2020) (Kg)
Figure 70. Australia Generic Injectables Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Generic Injectables Sales Growth Rate (2015-2020) (Kg)
Figure 72. Taiwan Generic Injectables Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Generic Injectables Sales Growth Rate (2015-2020) (Kg)
Figure 74. Indonesia Generic Injectables Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Generic Injectables Sales Growth Rate (2015-2020) (Kg)
Figure 76. Thailand Generic Injectables Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Generic Injectables Sales Growth Rate (2015-2020) (Kg)
Figure 78. Malaysia Generic Injectables Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Generic Injectables Sales Growth Rate (2015-2020) (Kg)
Figure 80. Philippines Generic Injectables Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Generic Injectables Sales Growth Rate (2015-2020) (Kg)
Figure 82. Vietnam Generic Injectables Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Generic Injectables Market Share by Type in 2019
Figure 84. Asia Pacific Generic Injectables Market Share by Application in 2019
Figure 85. Latin America Generic Injectables Sales Growth Rate 2015-2020 (Kg)
Figure 86. Latin America Generic Injectables Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Generic Injectables Sales Market Share by Country in 2019
Figure 88. Latin America Generic Injectables Revenue Market Share by Country in 2019
Figure 89. Mexico Generic Injectables Sales Growth Rate (2015-2020) (Kg)
Figure 90. Mexico Generic Injectables Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Generic Injectables Sales Growth Rate (2015-2020) (Kg)
Figure 92. Brazil Generic Injectables Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Generic Injectables Sales Growth Rate (2015-2020) (Kg)
Figure 94. Argentina Generic Injectables Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Generic Injectables Market Share by Type in 2019
Figure 96. Latin America Generic Injectables Market Share by Application in 2019
Figure 97. Middle East and Africa Generic Injectables Sales Growth Rate 2015-2020 (Kg)
Figure 98. Middle East and Africa Generic Injectables Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Generic Injectables Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Generic Injectables Revenue Market Share by Country in 2019
Figure 101. Turkey Generic Injectables Sales Growth Rate (2015-2020) (Kg)
Figure 102. Turkey Generic Injectables Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Generic Injectables Sales Growth Rate (2015-2020) (Kg)
Figure 104. Saudi Arabia Generic Injectables Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Generic Injectables Sales Growth Rate (2015-2020) (Kg)
Figure 106. U.A.E Generic Injectables Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Generic Injectables Market Share by Type in 2019
Figure 108. Middle East and Africa Generic Injectables Market Share by Application in 2019
Figure 109. North America Generic Injectables Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 110. North America Generic Injectables Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Generic Injectables Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 112. Europe Generic Injectables Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Generic Injectables Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 114. Asia Pacific Generic Injectables Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Generic Injectables Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 116. Latin America Generic Injectables Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Generic Injectables Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 118. Middle East and Africa Generic Injectables Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed
顔用注射剤の世界市場（～2026年） Injectables are a combination of dermal fillers and Botox used in facial aesthetic treatments, which help reduce wrinkles and play a crucial role in rejuvenating facial skin for smoother and younger look. These are injected under the skin or lips to plump up the tissues and gently lift it to restore…- ジェネリック医薬品有効成分の世界市場（～2026年） Market Analysis and Insights: Global Generic Active Pharmaceutical Ingredients Market The global Generic Active Pharmaceutical Ingredients market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Generic Active Pharmaceutical I…
- 動物用ジェネリック医薬品の世界市場（～2026年） Market Analysis and Insights: Global Animal Generic Drug Market The global Animal Generic Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Animal Generic Drug Scope and Market Size Animal Generic Drug market is seg…
- 吸入・点鼻薬ジェネリック医薬品の世界市場（～2026年） Inhalation and Nasal Spray is a kind of drug used to relieve sneezing, runny, stuffy, or itchy nose and itchy, watery eyes caused by hay fever or other allergies. Quality control could pose an issue in the overall growth of generic inhalers and nasal spray sales, an issue that governments are trying…
- 小分子創薬の世界市場（～2026年） Market Analysis and Insights: Global Small-Molecule Drug Discovery Market The global Small-Molecule Drug Discovery market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Small-Molecule Drug Discovery Scope and Market Size Sma…